Dear Sir
Shandong Kexing Bioproducts Co.,Ltd. is a biotech pharmaceutical enterprise.for the development,production and sales of genetic engineering product and microecological product. The company is equipped with two modernized production lines using eucaryotic cell and procaryotic cell expression systems for manufacturing of genetic engineering products , and an oral preparation workshop with annual capability of 400 million capsules (bags) of probiotics (capsule, powder),
The company is mainly engaged in the production and sale of three products including recombinant human erythropoietin injection (rh-EPO), recombinant human granulocyte colony-stimulating factor injection and Changlekang rh-EPO is the first genetic engineering and product put into domestic market, making our country the fourth to develop the product successfully following America, Japan and Germany in the world. In 1997, the product won the first EPO and new drug certificate and the first GNP certificate issued by our SFDA.
The company has successfully developed the market in India, Egypt, Indonesia, the Philippines, Pakistan and Brazil. New market in Iran, Chile and Syria are being developed.

Hope that we could cooperate in distribution of our finished drugs.

Look foward to hearing from you

Yours sincerely/Wenhua

Ad:TangWang Shan Rd,Mingshui Development Zone,Zhangqiu Shandong 250200,P.R China
Shandong Kexing Bioproducts Co.,Ltd

http://www.sdkexing.com
Tel:0086-13205418055
Fax:0086-531-83316484